Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.
about
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological TreatmentSAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).Chemical analysis and acetylcholinesterase inhibitory effect of anthocyanin-rich red leaf tea (cv. Sunrouge).Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
P2860
Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Structure-activity relationshi ...... y myasthenia gravis treatment.
@en
Structure-activity relationshi ...... y myasthenia gravis treatment.
@nl
type
label
Structure-activity relationshi ...... y myasthenia gravis treatment.
@en
Structure-activity relationshi ...... y myasthenia gravis treatment.
@nl
prefLabel
Structure-activity relationshi ...... y myasthenia gravis treatment.
@en
Structure-activity relationshi ...... y myasthenia gravis treatment.
@nl
P2093
P50
P1476
Structure-activity relationshi ...... ly myasthenia gravis treatment
@en
P2093
P304
P356
10.2174/092986710791111198
P577
2010-01-01T00:00:00Z